Paracetamol versus placebo in treatment of non-severe malaria in children in Guinea-Bissau: A randomized controlled trial

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Kofoed, Poul Erik ^a,b   Ursing, Johan ^c   Rodrigues, Amabelia ^a   Rombo, Lars ^a,c,d  

^a Projecto de Saúde de Bandim ^*  (Guinea-Bissau)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d Sormland County Council   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; PARACETAMOL; PLACEBO; QUINIMAX; ANTIPYRETIC AGENT;

ARTICLE; CHILD; CONTROLLED STUDY; CONVULSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG TREATMENT FAILURE; FEMALE; FEVER; FOLLOW UP; GUINEA-BISSAU; HUMAN; INFANT; INTERVIEW; LEUKOCYTE; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; OUTCOME ASSESSMENT; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; TEMPERATURE MEASUREMENT; ADOLESCENT; BODY TEMPERATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ISOLATION AND PURIFICATION; TREATMENT OUTCOME;

ACETAMINOPHEN; ADOLESCENT; ANTIPYRETICS; BODY TEMPERATURE; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; GUINEA-BISSAU; HUMANS; INFANT; INTERVIEWS AS TOPIC; MALARIA, FALCIPARUM; MALE; PLACEBOS; PLASMODIUM FALCIPARUM; TREATMENT OUTCOME;

EID: 79957648398     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-148     Document Type: Article

References (30)

1. Impact of temperature elevation on immunologic defenses. NJ Roberts Jr, Rev Infect Dis 1991 13 462 472 10.1093/clinids/13.3.462 1866550
2. AS El-Radhi, Is Fever Beneficial? Berlin: Springer-Verlag 2009
3. Paracetamol versus placebo or physical methods for treating fever in children (Review). M Meremikwu A Oyo-Ita, Cochrane Database Syst Rev 2009 D003676
4. Evidence on the use of paracetamol in febrile children. FM Russell F Shann N Curtis K Mulholland, Bull World Health Organ 2003 81 367 372 12856055 (Pubitemid 36644263)
5. Fulminant hepatic failure and paracetamol overuse with therapeutic intent in febrile children. SS Ranganathan MG Sathiadas S Sumanasena M Fernandopulle SP Lamabadusuriya BM Fernandopulle, Indian J Pediatr 2006 73 871 875 10.1007/BF02859276 17090896
6. Therapeutic misadventures with acetaminophen: hepatoxicity after multiple doses in children. JE Heubi MB Barbacci HJ Zimmerman, J Pediatr 1998 132 22 27 10.1016/S0022-3476(98)70479-2 9469995 (Pubitemid 28082526)
7. Paracetamol poisoning in children and hepatotoxicity. A Penna N Buchanan, Br J Clin Pharmacol 1991 32 143 149 1931463
8. Tumour necrosis factor, fever and fatality in falciparum malaria. D Kwiatkowski, Immunol Lett 1990 25 213 216 10.1016/0165-2478(90)90117-9 2283152 (Pubitemid 20260871)
9. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. ND Karunaweera GE Grau P Gamage R Carter KN Mendis, Proc Natl Acad Sci USA 1992 89 3200 3203 10.1073/pnas.89.8.3200 1565611
10. Antiparasitic effects of tumour necrosis factor in vivo and in vitro. JH Playfair J Taverne, Ciba Found Symp 1987 131 192 205 3131074
11. Febrile temperatures can synchronize the growth of Plasmodium falciparum in vitro. D Kwiatkowski, J Exp Med 1989 169 357 361 10.1084/jem.169.1.357 2642531 (Pubitemid 19035569)
12. Fever in uncomplicated Plasmodium falciparum infection: effects of quinine and paracetamol. S Krishna W Supanaranond S Pukrittayakamee KF ter Y Supputamangkol K Attatamsoonthorn,, et al. Trans R Soc Trop Med Hyg 1995 89 197 199 10.1016/0035-9203(95)90494-8 7778148
13. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. CH Brandts M Ndjave W Graninger PG Kremsner, Lancet 1997 350 704 709 10.1016/S0140-6736(97)02255-1 9291905 (Pubitemid 27371169)
14. W.H.O, Guidelines for the treatment of malaria 2010
15. Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6-7 years: analysis from Phase Three of the ISAAC programme. R Beasley T Clayton J Crane ME von CK Lai S Montefort A Stewart ISAAC Phase Three Study Group, Lancet 2008 372 1039 1048 10.1016/S0140-6736(08)61445-2 18805332
16. Treatment of children with Plasmodium falciparum malaria with chloroquine in Guinea-Bissau. PE Kofoed F Lopez P Johansson A Sandstrom K Hedegaard P Aaby L Rombo, Am J Trop Med Hyg 2002 67 28 31 12363060 (Pubitemid 35034316)
17. Different doses of amodiaquine and chloroquine for treatment of uncomplicated malaria in children in Guinea-Bissau: implications for future treatment recommendations. PE Kofoed J Ursing A Poulsen A Rodrigues Y Bergquist P Aaby L Rombo, Trans R Soc Trop Med Hyg 2007 101 231 238 10.1016/j.trstmh.2006. 05.008 16904718 (Pubitemid 46043055)
18. No benefits from combining chloroquine with artesunate for three days for treatment of Plasmodium falciparum in Guinea-Bissau. PE Kofoed A Poulsen F Co K Hedegaard P Aaby L Rombo, Trans R Soc Trop Med Hyg 2003 97 429 433 10.1016/S0035-9203(03)90078-2 15259473 (Pubitemid 39186025)
19. Multiplex PCR-RFLP methods for pfcrt, pfmdr1 and pfdhfr mutations in Plasmodium falciparum. MI Veiga PE Ferreira A Bjorkman JP Gil, Mol Cell Probes 2006 20 100 104 10.1016/j.mcp.2005.10.003 16460912 (Pubitemid 43343722)
20. What is meant by intention to treat analysis? Survey of published randomised controlled trials. S Hollis F Campbell, BMJ 1999 319 670 674 10480822 (Pubitemid 29423954)
21. Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. M Adjuik P Agnamey A Babiker S Borrmann P Brasseur M Cisse F Cobelens S Diallo JF Faucher P Garner S Gikunda PG Kremsner S Krishna B Lell M Loolpapit PB Matsiegui MA Missinou J Mwanza F Ntoumi P Olliaro P Osimbo P Rezbach E Some WR Taylor, Lancet 2002 359 1365 1372 10.1016/S0140-6736(02)08348-4 11978332 (Pubitemid 34442375)
22. ClinicalTrials.gov. ClinicalTrails, 2011 Ref Type: Online Source
23. Fever and survival. MJ Kluger DH Ringler MR Anver, Science 1975 188 166 168 10.1126/science.1114347 1114347
24. Fever: effect of drug-induced antipyresis on survival. HA Bernheim MJ Kluger, Science 1976 193 237 239 10.1126/science.935867 935867
25. Temperature as a factor in resistance of young puppies to canine herpesvirus. LE Carmichael FD Barnes DH Percy, J Infect Dis 1969 120 669 678 10.1093/infdis/120.6.669 4316062
26. Antipyretics in severe sepsis. F Shann, Lancet 1995 345 338 10.1016/S0140-6736(95)90337-2 7845113
27. Antipyretic measures for treating fever in malaria. M Meremikwu K Logan P Garner, Cochrane Database Syst Rev 2009 D002151
28. Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients. FO ter Kuile F Nosten C Luxemburger D Kyle P Teja-Isavatharm L Phaipun R Price T Chongsuphajaisiddhi NJ White, Bull World Health Organ 1995 73 631 642 8846489 (Pubitemid 26020629)
29. Early vomiting of mefloquine in children with malaria is not modified by the timing of antipyretic treatment. C Luxemburger VM van T Slight RN Price T Chongsuphajaisiddhi P Chanthavanich NJ White F Nosten, Trans R Soc Trop Med Hyg 1998 92 562 563 10.1016/S0035-9203(98)90916-6 9861381 (Pubitemid 28486491)
30. Antipyretic agents for preventing recurrences of febrile seizures: randomized controlled trial. T Strengell M Uhari R Tarkka J Uusimaa R Alen P Lautala H Rantala, Arch Pediatr Adolesc Med 2009 163 799 804 10.1001/archpediatrics.2009.137 19736332